CARDIOVASC DRUG THER - CARDIOVASCULAR DRUGS AND THERAPY
Publikationen
- 2021
Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
Arnold, N. & Koenig, W., 06.2021, in: CARDIOVASC DRUG THER. 35, 3, S. 627-635 9 S.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
- 2020
Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies
Brunetti, N. D., Tricarico, L., Tilz, R. R., Heeger, C-H., De Gennaro, L., Correale, M., Ieva, R., Di Biase, M., Rillig, A., Metzner, A. & Santoro, F., 04.2020, in: CARDIOVASC DRUG THER. 34, 2, S. 209-214 6 S.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
- 2009
Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: The epidemiological evidence
Koenig, W. & Khuseyinova, N., 02.2009, in: CARDIOVASC DRUG THER. 23, 1, S. 85-92 8 S.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung